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Abstract
Purpose. To determine if the use of combined HLA matched limbal stem cells allograft 
with amniotic membrane transplantation (AMT) is a safe and effective prophylactic 
surgical procedure to prevent corneal graft after penetrating keratoplasty (PK).
Methods. We report the case of a 17 years old patient with a history of congenital 
glaucoma, trabeculectomy and multiple corneal graft rejections, presenting total limbal 
cell deficiency. To reduce the possibility of graft rejection in the left eye after a new PK, 
a two step procedure was performed. At first the patient underwent a combined HLA 
matched limbal stem cells allograft (LAT) and AMT and then, 10 months later, a new 
PK.
Results. During 12 months of follow-up, the corneal graft remained stable and smooth, 
with no sign of graft rejection.
Conclusions. In our patient, the prophylactic use of LAT from HLA-matched donors 
and AMT before PK, may result in a better prognosis of corneal graft survival.
INTRODUCTION
The corneal epithelium maintains homeostasis 
by balancing desquamation from the surface and 
proliferation of the basal cells plus centripetal movement 
from the stem cells located at the limbus [1]. When the 
corneal limbus is severely damaged (limbal stem cell 
deficiency, LSCD), conjunctival epithelium replaces 
the corneal epithelium, which causes significant visual 
deterioration. The surgical prognosis of penetrating 
keratoplasty (PK) in eyes with limbal dysfunction 
remains very poor, because the epithelium on the graft 
is not supplied by stem cells [2]. The autograft limbal 
stem cells transplantation was described for the first 
time in 1989 [3] and recently transplantation of the 
limbal tissues using either autografts [4-6] or allografts 
(limbal allograft transplantation, LAT) has been 
proposed for the treatment of limbal dysfunction [4]. 
As described by Kolli et al. [5], the use of stratified 
cultivated oral mucosa epithelium was successfull in 
two patients with bilateral total LSCD with reversal 
of the deficit up to 24 months. Zakaria et al. [6] 
described the results of a cultivated limbal stem cell 
protocol in a prospective phase I/II non-randomized 
clinical trial in 18 consecutive patients with total and 
partial limbal stem cell deficiency. Their standardized, 
non-xenogenic, reduced manipulation cultivation and 
surgical transplantation of limbal stem cell grafts has 
shown to be a safe and effective treatment option for 
patients with LSCD.
One major concern, however, about the autologous 
transplantation of limbal epithelial stem cells is the 
wellbeing of the donor fellow eye, from which one third 
to a half of the limbal circumference has been removed. 
So, when also the fellow eye show damage of the limbal 
stem cells, the allograft transplantation is the safer 
treatment option. The tissues used for the LAT can 
be obtained by living donor or eye bank eyes [4]. One 
important problem concerning allografts is that, in most 
of the cases, it is not HLA matched and so it requires 
prolonged, if not indefinite, immunosuppression.
HLA mAtcHed LimbAL stem witH Amt in PK
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
299
An alternative surgical solution that can help to 
restore corneas with limbal cell defects is amniotic 
membrane transplantation (AMT). Tseng et al. [7] have 
demonstrated that AMT is effective in treating partial 
limbal stem cell defects.
We report the case of the use of combined HLA 
matched limbal stem cells allograft with AMT as a 
prophylactic surgical procedure to prevent corneal graft 
rejection after PK.
REPORT OF A CASE
A 17-year-old girl with a history of congenital 
glaucoma in both eyes had her intraocular pressure 
(IOP) normal after bilateral trabeculectomy and 
Baerveldt valve implant, performed during the first years 
of her life. Due to her primary ocular pathology and 
even if a normal IOP, she presented a bilateral corneal 
opacification, necessiting a bilateral PK. Postoperative 
examination of the anterior segment of the right eye 
showed an excellent result with a clear corneal graft 
and a final visual acuity of 20/40. Differently, the left 
eye presented a severe corneal edema and cloudiness. 
The left corneal graft condition allowed us to perform a 
second PK in this eye. Unfortunatly also the second and 
then the third PK did not show accettable postoperative 
results: the left corneal graft eye cornea had diffuse 
superficial neovascularization and stromal cloudiness. 
The duration of the trasparency of the graft after the 
third PK was only eighteen days. 
To reduce the possibility of graft rejection in the left 
eye after a new PK, a new surgical approach was taken 
in exam. Anterior segment examination of the left eye 
showed a total limbal cell deficiency and so the autologous 
transplantation of limbal epithelial stem cells was not 
performable. The HLA analisys of the patient’s sister was 
assessed and showed a complete HLA match. And so a 
two step procedure was performed. At first the patient 
underwent a combined HLA matched limbal stem cells 
allograft and AMT and then, 10 months later, a new PK.
Surgical techniques
Penetrating keratoplasty
The donor cornea was trephinated with a punch and 
the receiving cornea with a suction trephinator. The 
trephination diameter in the receiving cornea is in the 
range of 7.5-7.75 mm, both with a donor trephination 
0.25-0.5 mm larger. Viscoelastic material is placed on 
the surface of the receiving cornea and the graft is placed 
on top of it and affixed with symmetrical points (nylon 
10.0) at 6 and 12 hours. Having affixed the two points, 
The third and the fourth point are placed at 3 and 9 
hours and then the suture of the graft is completed with 
single sutures (Figure 1, A-D).
Limbal stem cells allograft and amniotic membrane 
transplantation
To obtain steam cell allograft, the sister’s donor eye 
underwent a removal of 2 patches both consisting in 7 
mm of conjunctiva and 2 mm of clear cornea taken at 
6 and 12 hours. 
One patch was obtained with manual escission, while 
the other using the 60 kHz IntraLase femtosecond 
laser (IntraLase FS Laser, Abbott Medical Optics, 
Inc.) loaded with the IntraLase-enabled keratoplasty 
computer (Figure1, E, F).
Amniotic membrane was sutured on the receiving 
cornea with Nylon 10.0 stiches and then, above HAM, 
the 2 patches were sutured at 6 and 12 hours: vycril 8.0 
was used for the conjunctival stiches and nylon 10.0 for 
the corneal ones (Figure1, G).
Figure 1 
Legend: Preoperative clinical condition is showed in (A).  After donor trephination is perfomed, the wide iridectomy, performed 
in the previous surgery for congenital glaucoma, and corectopia are visible (B). Pupilloplatic is performed (C). The corneal graft is 
finally sutured with single stiches (D). Laser assisted (E) and manual (F) removal of donor patches consisting in 7mm of conjunctiva 
and 2mm of clear cornea. In (E) the carton mask positioned over the laser lens to obtain the laser cut corneal- conjunctival patch is 
shown. Amniotic membrane was then sutured (G). The corneal graft of the left eye remained stable and smooth, with clear stroma 
and no sign of graft rejection (H).
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During 12 months of follow-up, the corneal graft of the 
left eye remained stable and smooth, with clear stroma 
and no sign of graft rejection. The best-corrected visual 
acuity improved to 4/20 The IOP was11 mmHg. No 
complications were found in the donor eye (Figure1, H).
DISCUSSION
The amniotic membrane has effectively been used 
as a temporary patch to promote healing of the ocular 
surface by reducing inflammation and scar formation 
[8]. This healing effect lends its use in multiple cases 
of ocular surface pathology, including corneal ulcers, 
severe ocular surface desiccation from chemical and 
thermal burns, limbal stem cell deficiency, and scleral 
melt [9, 10]. Recent studies and applications of 
amniotic membrane provide confirmation of earlier 
investigations and there is mounting agreement that 
early intervention with amniotic transplantation in 
cases of severe pathology is key to preserving the ocular 
surface and ameliorating visual function.
The autografts or allografts has been proposed 
for the treatment of with LSCD [4-6]. The surgical 
option and postoperative success of the limbal stem 
cells transplantation technique depend on the health 
of patient’s limbal stem cells (LSCs). Autograft is not 
applicable to patients with bilateral LSCD where there 
are no remaining LSCs.
Limbal allograft transplantation from a heterologous 
donor has been shown to be effective and safe methods 
of treatment for corneal surface reconstruction because 
of various aetiologies. The disadvantages of limbal 
allografting are the risk of graft rejection and side 
effects of systemic immunosuppression against limbal 
autografting.
However, risk of graft rejection, discontinuation of 
immunosuppression, advanced stage ocular surface 
problems particularly as in these eyes, difficulty of 
finding HLA-matched donors, and availablity of 
sufficient amount of graft tissue from donor eye, were 
all reported to worsen the surgical outcomes in these 
patients. We presume that the success of our case 
is due to the rarity of finding a 100% HLA matched 
donor, avoiding sistemic immunosuppression. Despite 
its capacity of improving graft survival, systemic 
immunosuppresion has an important morbidity being 
a long lasting therapy.
In conclusion, LAT from HLA-matched donors 
combining it with penetrating keratoplasty may result 
in a better prognosis of graft survival and improved 
visual function in these eyes. 
Even if we realize that it is not possible to extrapolate 
a general guideline from 1 case report, our success 
warrants others to consider such an option when 
considering the risk in the donor eye during the 
treatment of unilateral LSCD.
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